These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Completed, but no date||2004-004693-87||Randomized study on therapy of Strongyloides stercoralis invasion: ivermectine VS thiabendazole||bad-data|
|Completed, but no date||2006-002424-42||Evaluation of Safety and Efficacy on Visual Acuity Outcome and Choroidal Neovascularization of Intravitreal Somministration of Bevacizumab Avastin, Roche, United Kingdom in patients with Subfoveal C...||bad-data|
|Completed, but no date||2006-005315-10||Evaluation of safety and efficacy on visual acuity outcome of intravitreal somministration of Bevacizumab in patients with diabetic retinopathy||bad-data|
|Ongoing||2011-001724-38||Use of 68-Ga-DOTANOC for the assessment of human neuroendocrine tumors by imaging with Positron Emission Tomography (PET) Impiego del 68-Ga-DOTANOC nella diagnostica per immagini mediante Tomografi...||not-yet-due|
|Other||2011-002784-24||Randomized, Open-label, Multi Centre Phase III Clinical Trial on Multiple versus Single Dose of Ivermectin for the Treatment of Strongyloides||not-yet-due|
|Ongoing||2018-003652-21||Interventional two arms open-label study for evaluating the diagnostic performance of PET PSMA in patients affected by biochemical recurrent prostate cancer. Studio interventistico a due braccia, i...||not-yet-due|
|Ongoing||2020-002283-32||Randomized, Double-blind, Multi Centre Phase II, Proof of Concept, Dose Finding Clinical Trial on Ivermectin for the early Treatment of COVID-19 Studio clinico randomizzato, in doppio cieco, multic...||not-yet-due|